AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 5,966.05
+43.45 (0.73%)
At close: Oct 16, 2026
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 149.15 billion as of October 16, 2026. It is the 7,824th most valuable company in the world and the 466th biggest in India. Its market cap has decreased by 34.99% in one year.
Market Cap
149.15B
Enterprise Value
145.78B
Revenue
24.32B
Global Rank
Country Rank
#466 India
PE Ratio
87.93
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 149.15B, an increase of 10,186.29%. That is a compound annual growth rate of 20.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 149.15B | -33.78% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 427.41B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 201.45B |
| Caplin Point Laboratories | 175.06B |
| Jubilant Pharmova | 148.59B |
| Viyash Scientific | 98.55B |
| Procter & Gamble Health | 85.68B |
| Bliss GVS Pharma | 69.75B |